|
|
|
|
|
|
by maxerickson
3324 days ago
|
|
|
I don't really have a strong opinion about either issue, but it isn't necessarily incoherent to simply want the FDA be be better in both cases. Like what if some of the requirements for new drugs are arbitrary (slowing approval) and the standard of proof for novel release mechanisms is too low? |
|
|